— Know what they know.
Not Investment Advice

096530.KQ KOE

Seegene, Inc.
1W: +9.2% 1M: +11.8% 3M: +28.6% YTD: +36.2% 1Y: +23.8% 3Y: +91.1% 5Y: -49.0%
₩36,900.00 ($27.48)
-400.00 (-1.07%)
 
Weekly Expected Move ±5.1%
₩33135 ₩35017 ₩36900 ₩38783 ₩40665
KOE · Healthcare · Medical - Specialties · Tech Score Strong Buy · Power 70 · ₩1.68T mcap · 31M float · 1.09% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩1.68T ($1.3B)
52W Range21700-37650
Volume243,828
Avg Volume331,076
Beta0.88
Dividend₩1200.00
Analyst Ratings
No analyst coverage
Company Info
CEOJong-Yoon Cheon
Employees822
SectorHealthcare
IndustryMedical - Specialties
IPO Date2010-09-10
Taewon Building
Seoul, SL 05548
KR
82 2 2240 4000
About Seegene, Inc.

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms